Table 4 Number of drug targets in top 1, 5, 10, 15 and 20 % of the essential non-homologous proteins
Non-homologous Essential proteins | Number of validated drug targets |
|---|---|
1 %(5) | 2 |
5 %(26) | 4 |
10 %(53) | 13 |
15 %(80) | 21 |
20 %(107) | 21 |
Non-homologous Essential proteins | Number of validated drug targets |
|---|---|
1 %(5) | 2 |
5 %(26) | 4 |
10 %(53) | 13 |
15 %(80) | 21 |
20 %(107) | 21 |